Your session is about to expire
← Back to Search
Natalizumab for Multiple Sclerosis
Study Summary
This trial will test if Natalizumab can help to restore and repair the blood brain barrier in people with multiple sclerosis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have never been treated with Natalizumab.I am eligible for Natalizumab treatment.I have been diagnosed with multiple sclerosis.
- Group 1: Treatment Single Arm
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent has recruitment for this medical study been successful?
"Affirmative, clinicaltrials.gov indicates that this study launched on September 16th and was most recently updated two days later. The trial requires 36 volunteers from a single medical site."
Are participants being accepted for the current iteration of this trial?
"Affirmative. Information available on clinicaltrials.gov confirms that this medical experiment, initially published on September 16th 2022, is actively looking for participants. The study requires 36 volunteers to be enrolled at a single site."
Is this treatment method reliable and secure for individuals?
"A score of 3 was assigned to this treatment's safety, as it has been approved by the FDA and is in its fourth phase of trials."
Does the trial's eligibility criteria encompass individuals over 80?
"This clinical trial is seeking individuals aged 18 to 65. There are 43 trials targeting minors and 391 for those over the age of retirement."
Is there an opportunity for me to volunteer in this research endeavor?
"This medical trial is currently enrolling 36 individuals, aged 18-65 years old and afflicted with multiple sclerosis. To be eligible for this study, participants must not have had prior exposure to Natalizumab treatment."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger